{"database": "lobbying", "table": "lobbying_activities", "rows": [[3194792, "b088f369-911e-4fc6-ac2e-ce76ea191684", "Q2", "BURRELL INTERNATIONAL GROUP LLC", 401103483, "TONIX PHARMACEUTICALS HOLDING CORP.", 2024, "second_quarter", "PHA", "LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY25 Defense Appropriation for broad-spectrum antivirals, FY25 LHHS for long covid and cocaine overdose funding", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-16T16:30:38-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3194792"], "units": {}, "query_ms": 0.4114799667149782, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}